Tectonic Therapeutic, Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
TECX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 210, Watertown, Massachusetts

Insiders trading volume in the past year

Tectonic Therapeutic, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Timothy A. Springer Director, 10%+ Owner $5.52M Jun 20, 2024
Braden M. Leonard Former 10% owner of AVROBIO $564K +$971K Jun 20, 2024
Alise Reicin Chief Executive Officer, Director $378K Jun 20, 2024
Geoffrey Mackay President & CEO, Director $361K Feb 8, 2023
Azadeh Golipour Chief Technology Officer $202K Feb 1, 2024
Erik Ostrowski Interim CEO, President and CFO $180K Feb 1, 2024
Christian Cortis Chief Operating Officer $164K Jun 20, 2024
Steven Avruch Chief Legal Officer $145K Feb 1, 2024
Essra Ridha Chief Medical Officer $137K Feb 1, 2024
Deanna M. Petersen Chief Business Officer $104K Feb 8, 2023
Terrance Mcguire Director $84K Jun 20, 2024
Marcella K. Ruddy Chief Medical Officer $41.7K Jun 20, 2024
Stefan Vitorovic Director $36.1K Jun 20, 2024
Peter McNamara Chief Scientific Officer $13.9K Jun 20, 2024
Praveen P. Tipirneni Director $3.95K Jun 20, 2024
Ian T. Clark Director Jun 6, 2023
Bruce Booth Director Jun 6, 2023
Annalisa Jenkins Director Jun 6, 2023
Diana Escolar Chief Medical Officer Jun 10, 2021
Christopher Mason Chief Scientific Officer Jun 10, 2021
Christopher Paige Director Jun 6, 2023
Philip J. Vickers Director Jun 6, 2023
Gail M. Farfel Director Jun 6, 2023
Marc Schwabish Chief Business Officer Jun 20, 2024
Phillip B. Donenberg Director Jun 20, 2024
Daniel Lochner Chief Financial Officer Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for Tectonic Therapeutic, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.